Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Non-Current Debt (2018 - 2019)

Historic Non-Current Debt for 10x Genomics (TXG) over the last 2 years, with Q4 2019 value amounting to $19.8 million.

  • 10x Genomics' Non-Current Debt fell 2217.43% to $19.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $19.8 million, marking a year-over-year decrease of 2217.43%. This contributed to the annual value of $19.8 million for FY2019, which is 2217.43% down from last year.
  • According to the latest figures from Q4 2019, 10x Genomics' Non-Current Debt is $19.8 million, which was down 2217.43% from $22.3 million recorded in Q3 2019.
  • 10x Genomics' 5-year Non-Current Debt high stood at $25.5 million for Q4 2018, and its period low was $19.8 million during Q4 2019.